https://www.selleckchem.com/pr....oducts/l-mimosine.ht
https://www.selleckchem.com/pr....oducts/l-mimosine.ht
Real-World Compliance to be able to OnabotulinumtoxinA Strategy to Spasticity: Observations in the ASPIRE Study. Significant differences were noted in the rate of CMA among children with facial eczema of exudation (adjusted odds ratio 2.398; P = 0.017) and papules (adjusted odds ratio 2.787; P = 0.008), using multivariate analysis. The rate of IgE-mediated CMA was high among children with atopic disease having severe facial eczema during infancy. The rate of IgE-mediated CMA
Curtir
Comentario
Compartilhar
